{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Catechin gallate", "Deep learning", "Main protease", "Molecular docking", "SARS-CoV-2"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36931201", "DateCompleted": {"Year": "2023", "Month": "03", "Day": "31"}, "DateRevised": {"Year": "2023", "Month": "04", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.1016/j.compbiomed.2023.106785", "S0010-4825(23)00250-0"], "Journal": {"ISSN": "1879-0534", "JournalIssue": {"Volume": "157", "PubDate": {"Year": "2023", "Month": "May"}}, "Title": "Computers in biology and medicine", "ISOAbbreviation": "Comput Biol Med"}, "ArticleTitle": "Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M<sup>pro</sup>) using molecular docking and deep learning methods.", "Pagination": {"StartPage": "106785", "MedlinePgn": "106785"}, "Abstract": {"AbstractText": ["Highly transmissive and rapidly evolving Coronavirus disease-2019 (COVID-19), a viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), triggered a global pandemic, which is one of the most researched viruses in the academia. Effective drugs to treat people with COVID-19 have yet to be developed to reduce mortality and transmission. Studies on the SARS-CoV-2 virus identified that its main protease (M<sup>pro</sup>) might be a potential therapeutic target for drug development, as this enzyme plays a key role in viral replication. In search of potential inhibitors of M<sup>pro</sup>, we developed a phytochemical library consisting of 2431 phytochemicals from 104 Korean medicinal plants that exhibited medicinal and antioxidant properties. The library was screened by molecular docking, followed by revalidation by re-screening with a deep learning method. Recurrent Neural Networks (RNN) computing system was used to develop an inhibitory predictive model using SARS coronavirus M<sup>pro</sup> dataset. It was deployed to screen the top 12 compounds based on their docked binding affinity that ranged from -8.0 to -8.9\u00a0kcal/mol. The top two lead compounds, Catechin gallate and Quercetin 3-O-malonylglucoside, were selected depending on inhibitory potency against M<sup>pro</sup>. Interactions with the target protein active sites, including His41, Met49, Cys145, Met165, and Thr190 were also examined. Molecular dynamics simulation was performed to analyze root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration (RG), solvent accessible surface area (SASA), and number of hydrogen bonds. Results confirmed the inflexible nature of the docked complexes. Absorption, distribution, metabolism, excretion, and toxicity (ADMET), as well as bioactivity prediction confirmed the pharmaceutical activities of the lead compound. Findings of this research might help scientists to optimize compatible drugs for the treatment of COVID-19 patients."], "CopyrightInformation": "Copyright \u00a9 2023 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh. Electronic address: s1910861106@ru.ac.bd."}], "LastName": "Hossain", "ForeName": "Alomgir", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Rahman", "ForeName": "Md Ekhtiar", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Rahman", "ForeName": "Md Siddiqur", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Nasirujjaman", "ForeName": "Khondokar", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Matin", "ForeName": "Mohammad Nurul", "Initials": "MN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Computer Science and Engineering, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Faruqe", "ForeName": "Md Omar", "Initials": "MO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Yeungnam University, Gyeongsan, Gyeongsangbuk-do, 38541, Republic of Korea. Electronic address: rabbi.biotech@gmail.com."}], "LastName": "Rabbee", "ForeName": "Muhammad Fazle", "Initials": "MF"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Comput Biol Med", "NlmUniqueID": "1250250", "ISSNLinking": "0010-4825"}, "ChemicalList": [{"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "3C-like proteinase, SARS-CoV-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Deep Learning"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}], "CoiStatement": "Declaration of competing interest The authors declare that they have no known conflict of interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Cascella M., Rajnik M., Aleem A., Dulebohn S.C., Di Napoli R. 2022. Features, Evaluation, and Treatment of Coronavirus (COVID-19) Statpearls [Internet]", "ArticleIdList": ["32150360"]}, {"Citation": "Chan J.F.-W., Kok K.-H., Zhu Z., Chu H., To K.K.-W., Yuan S., Yuen K.-Y. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microb. Infect. 2020;9:221\u2013236.", "ArticleIdList": ["PMC7067204", "31987001"]}, {"Citation": "Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W., Tian J.-H., Pei Y.-Y. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265\u2013269.", "ArticleIdList": ["PMC7094943", "32015508"]}, {"Citation": "Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565\u2013574.", "ArticleIdList": ["PMC7159086", "32007145"]}, {"Citation": "Naqvi A.A.T., Fatima K., Mohammad T., Fatima U., Singh I.K., Singh A., Atif S.M., Hariprasad G., Hasan G.M., Hassan M.I. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2020;1866", "ArticleIdList": ["PMC7293463", "32544429"]}, {"Citation": "Lee H.-J., Shieh C.-K., Gorbalenya A.E., V Koonin E., La Monica N., Tuler J., Bagdzhadzhyan A., Lai M.M.C. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology. 1991;180:567\u2013582.", "ArticleIdList": ["PMC7131164", "1846489"]}, {"Citation": "Ziebuhr J., Snijder E.J., Gorbalenya A.E. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. 2000;81:853\u2013879.", "ArticleIdList": ["10725411"]}, {"Citation": "Anand K., Palm G.J., Mesters J.R., Siddell S.G., Ziebuhr J., Hilgenfeld R. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra \u03b1-helical domain. EMBO J. 2002;21:3213\u20133224.", "ArticleIdList": ["PMC126080", "12093723"]}, {"Citation": "Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763\u20131767.", "ArticleIdList": ["12746549"]}, {"Citation": "Yang H., Yang M., Ding Y., Liu Y., Lou Z., Zhou Z., Sun L., Mo L., Ye S., Pang H. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. USA. 2003;100:13190\u201313195.", "ArticleIdList": ["PMC263746", "14585926"]}, {"Citation": "Chou C.-Y., Chang H.-C., Hsu W.-C., Lin T.-Z., Lin C.-H., Chang G.-G. Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease. Biochemistry. 2004;43:14958\u201314970.", "ArticleIdList": ["15554703"]}, {"Citation": "Hsu M.-F., Kuo C.-J., Chang K.-T., Chang H.-C., Chou C.-C., Ko T.-P., Shr H.-L., Chang G.-G., Wang A.H.-J., Liang P.-H. Mechanism of the maturation process of SARS-CoV 3CL protease*[boxs] J. Biol. Chem. 2005;280:31257\u201331266.", "ArticleIdList": ["PMC8062786", "15788388"]}, {"Citation": "Morse J.S., Lalonde T., Xu S., Liu W.R. Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019\u2010nCoV. Chembiochem. 2020;21:730\u2013738.", "ArticleIdList": ["PMC7162020", "32022370"]}, {"Citation": "Hayden F.G., Turner R.B., Gwaltney J.M., Chi-Burris K., Gersten M., Hsyu P., Patick A.K., Smith G.J., III, Zalman L.S. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob. Agents Chemother. 2003;47:3907\u20133916.", "ArticleIdList": ["PMC296196", "14638501"]}, {"Citation": "Jain R., Mujwar S. Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19. Struct. Chem. 2020;31:2487\u20132499.", "ArticleIdList": ["PMC7418093", "32837119"]}, {"Citation": "Thiel V., Ivanov K.A., Putics A., Hertzig T., Schelle B., Bayer S., Wei\u00dfbrich B., Snijder E.J., Rabenau H., Doerr H.W. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 2003;84:2305\u20132315.", "ArticleIdList": ["12917450"]}, {"Citation": "Su H., Yao S., Zhao W., Li M., Liu J., Shang W., Xie H., Ke C., Gao M., Yu K. BioRxiv; 2020. Discovery of Baicalin and Baicalein as Novel, Natural Product Inhibitors of SARS-CoV-2 3CL Protease in Vitro."}, {"Citation": "Yang H., Xie W., Xue X., Yang K., Ma J., Liang W., Zhao Q., Zhou Z., Pei D., Ziebuhr J. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol. 2005;3:e324.", "ArticleIdList": ["PMC1197287", "16128623"]}, {"Citation": "Xue X., Yang H., Shen W., Zhao Q., Li J., Yang K., Chen C., Jin Y., Bartlam M., Rao Z. Production of authentic SARS-CoV Mpro with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction. J. Mol. Biol. 2007;366:965\u2013975.", "ArticleIdList": ["PMC7094453", "17189639"]}, {"Citation": "Islam M.T., Sarkar C., El\u2010Kersh D.M., Jamaddar S., Uddin S.J., Shilpi J.A., Mubarak M.S. Natural products and their derivatives against coronavirus: a review of the non\u2010clinical and pre\u2010clinical data. Phytother Res. 2020;34:2471\u20132492.", "ArticleIdList": ["32248575"]}, {"Citation": "Shah M.A., Rasul A., Yousaf R., Haris M., Faheem H.I., Hamid A., Khan H., Khan A.H., Aschner M., Batiha G.E. Combination of natural antivirals and potent immune invigorators: a natural remedy to combat COVID\u201019. Phytother Res. 2021;35:6530\u20136551.", "ArticleIdList": ["PMC8441799", "34396612"]}, {"Citation": "Sharma M., Prasher P., Mehta M., Zacconi F.C., Singh Y., Kapoor D.N., Dureja H., Pardhi D.M., Tambuwala M.M., Gupta G. Drug Development Research; 2020. Probing 3CL Protease: Rationally Designed Chemical Moieties for COVID-19.", "ArticleIdList": ["32729640"]}, {"Citation": "Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289\u2013293.", "ArticleIdList": ["32272481"]}, {"Citation": "Chen L., Gui C., Luo X., Yang Q., G\u00fcnther S., Scandella E., Drosten C., Bai D., He X., Ludewig B. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J. Virol. 2005;79:7095\u20137103.", "ArticleIdList": ["PMC1112131", "15890949"]}, {"Citation": "Ortega J.T., Serrano M.L., Jastrzebska B. Class AG protein-coupled receptor antagonist famotidine as a therapeutic alternative against SARS-CoV2: an in silico analysis. Biomolecules. 2020;10:954.", "ArticleIdList": ["PMC7355875", "32599963"]}, {"Citation": "Liu X., Wang X.-J. Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines. J. Genetics Genom. 2020;47:119.", "ArticleIdList": ["PMC7128649", "32173287"]}, {"Citation": "Hilgenfeld R. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J. 2014;281:4085\u20134096.", "ArticleIdList": ["PMC7163996", "25039866"]}, {"Citation": "Mengist H.M., Dilnessa T., Jin T. Structural basis of potential inhibitors targeting SARS-CoV-2 main protease. Front. Chem. 2021;9", "ArticleIdList": ["PMC8056153", "33889562"]}, {"Citation": "Adegbola P.I., Semire B., Fadahunsi O.S., Adegoke A.E. Molecular docking and ADMET studies of Allium cepa, Azadirachta indica and Xylopia aethiopica isolates as potential anti-viral drugs for Covid-19. VirusDisease. 2021;32:85\u201397.", "ArticleIdList": ["PMC8036013", "33869672"]}, {"Citation": "Pitsillou E., Liang J.J., Beh R.C., Hung A., Karagiannis T.C. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain. Comput. Biol. Med. 2022;149", "ArticleIdList": ["PMC9420038", "36055162"]}, {"Citation": "Kumar Y., Singh H., Patel C.N. Silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. J. Infect. Public Health. 2020;13:1210\u20131223.", "ArticleIdList": ["PMC7297718", "32561274"]}, {"Citation": "Bafna K., Krug R.M., Montelione G.T. ChemRxiv; 2020. Structural Similarity of SARS-CoV2 Mpro and HCV NS3/4A Proteases Suggests New Approaches for Identifying Existing Drugs Useful as COVID-19 Therapeutics."}, {"Citation": "Liu Q., Kwan K., Cao T., Yan B., Ganesan K., Jia L., Zhang F., Lim C., Wu Y., Feng Y. Broad\u2010spectrum antiviral activity of Spatholobus suberectus Dunn against SARS\u2010CoV\u20102, SARS\u2010CoV\u20101, H5N1, and other enveloped viruses. Phytother Res. 2022;36:3232\u20133247.", "ArticleIdList": ["PMC9537938", "35943221"]}, {"Citation": "Kaplan W., Littlejohn T.G. Swiss-PDB viewer (deep view) Briefings Bioinf. 2001;2:195\u2013197.", "ArticleIdList": ["11465736"]}, {"Citation": "Arshia A.H., Shadravan S., Solhjoo A., Sakhteman A., Sami A. De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations. Comput. Biol. Med. 2021;139 doi: 10.1016/j.compbiomed.2021.104967.", "ArticleIdList": ["10.1016/j.compbiomed.2021.104967", "PMC8545757", "34739968"]}, {"Citation": "Trott O., Olson A.J., Vina AutoDock. Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455\u2013461.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Murugesan S., Kottekad S., Crasta I., Sreevathsan S., Usharani D., Perumal M.K., Mudliar S.N. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants\u2013Emblica officinalis (Amla), Phyllanthus niruri Linn.(Bhumi Amla) and Tinospora cordifolia (Giloy)\u2013A molecular docking and simulation study. Comput. Biol. Med. 2021;136", "ArticleIdList": ["PMC8302490", "34329860"]}, {"Citation": "Liu Z., Du J., Fang J., Yin Y., Xu G., Xie L. 2019. DeepScreening : a Deep Learning-Based Screening Web Server for Accelerating Drug Discovery; pp. 1\u201311.", "ArticleIdList": ["10.1093/database/baz104", "PMC6790966", "31608949"]}, {"Citation": "Yap C.W.E.I. 2010. Software News and Update PaDEL-Descriptor : an Open Source Software to Calculate Molecular Descriptors and Fingerprints.", "ArticleIdList": ["10.1002/jcc", "21425294"]}, {"Citation": "ting Fu T., Tu G., Ping M., xun Zheng G., yuan Yang F., yi Yang J., Zhang Y., jun Yao X., wei Xue W., Zhu F. Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors. Acta Pharmacol. Sin. 2021;42:1354\u20131367. doi: 10.1038/s41401-020-00541-z.", "ArticleIdList": ["10.1038/s41401-020-00541-z", "PMC8285414", "33122823"]}, {"Citation": "Xue W., Wang P., Tu G., Yang F., Zheng G., Li X., Li X., Chen Y., Yao X., Zhu F. Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder. Phys. Chem. Chem. Phys. 2018;20:6606\u20136616. doi: 10.1039/c7cp07869b.", "ArticleIdList": ["10.1039/c7cp07869b", "29451287"]}, {"Citation": "Krieger E., Darden T., Nabuurs S.B., Finkelstein A., Vriend G. Making optimal use of empirical energy functions: force\u2010field parameterization in crystal space. Proteins: Struct., Funct., Bioinf. 2004;57:678\u2013683.", "ArticleIdList": ["15390263"]}, {"Citation": "Case D.A., Cheatham T.E., III, Darden T., Gohlke H., Luo R., Merz K.M., Jr., Onufriev A., Simmerling C., Wang B., Woods R.J. The Amber biomolecular simulation programs. J. Comput. Chem. 2005;26:1668\u20131688.", "ArticleIdList": ["PMC1989667", "16200636"]}, {"Citation": "Krieger E., Nielsen J.E., Spronk C.A.E.M., Vriend G. Fast empirical pKa prediction by Ewald summation. J. Mol. Graph. Model. 2006;25:481\u2013486.", "ArticleIdList": ["16644253"]}, {"Citation": "M. Dutta, A.M. Tareq, A. Rakib, S. Mahmud, S.A. Sami, J. Mallick, M.N. Islam, M. Majumder, Z. Uddin, A. Alsubaie, A.S.A. Almalki, M.U. Khandaker, D.A. Bradley, S. Rana, T. Bin Emran, Molecular Dynamics Simulations, (2021).", "ArticleIdList": ["PMC8389631", "34440024"]}, {"Citation": "Tu G., Fu T., Yang F., Yang J., Zhang Z., Yao X., Xue W., Zhu F. Understanding the polypharmacological profiles of triple reuptake inhibitors by molecular simulation. ACS Chem. Neurosci. 2021;12:2013\u20132026. doi: 10.1021/acschemneuro.1c00127.", "ArticleIdList": ["10.1021/acschemneuro.1c00127", "33977725"]}, {"Citation": "Krieger E., Vriend G. New ways to boost molecular dynamics simulations. J. Comput. Chem. 2015;36:996\u20131007.", "ArticleIdList": ["PMC6680170", "25824339"]}, {"Citation": "Mahmud S., Parves M.R., Riza Y.M., Sujon K.M., Ray S., Tithi F.A., Zaoti Z.F., Alam S., Absar N. Exploring the potent inhibitors and binding modes of phospholipase A2 through in silico investigation. J. Biomol. Struct. Dyn. 2020;38:4221\u20134231.", "ArticleIdList": ["31607222"]}, {"Citation": "Khan M.A., Mahmud S., Alam A.S.M.R.U., Rahman M.E., Ahmed F., Rahmatullah M. Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study. J. Biomol. Struct. Dyn. 2021;39:6317\u20136323.", "ArticleIdList": ["PMC7441768", "32696718"]}, {"Citation": "Islam M.J., Parves M.R., Mahmud S., Tithi F.A., Reza M.A. Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach. Comput. Biol. Chem. 2019;80:31\u201345.", "ArticleIdList": ["30884445"]}, {"Citation": "Parida P.K., Paul D., Chakravorty D. The natural way forward: molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS\u2010CoV\u20102 targets. Phytother Res. 2020;34:3420\u20133433.", "ArticleIdList": ["PMC7537166", "32969524"]}, {"Citation": "Lee J., Kenward C., Worrall L.J., Vuckovic M., Gentile F., Ton A.-T., Ng M., Cherkasov A., Strynadka N.C.J., Paetzel M. X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation. Nat. Commun. 2022;13:1\u201313.", "ArticleIdList": ["PMC9440467", "36057636"]}, {"Citation": "Vuong W., Fischer C., Khan M.B., van Belkum M.J., Lamer T., Willoughby K.D., Lu J., Arutyunova E., Joyce M.A., Saffran H.A. Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: structural enhancements, increased solubility, and micellar studies. Eur. J. Med. Chem. 2021;222", "ArticleIdList": ["PMC8164773", "34118724"]}, {"Citation": "V Stoddard S., Stoddard S.D., Oelkers B.K., Fitts K., Whalum K., Whalum K., Hemphill A.D., Manikonda J., Martinez L.M., Riley E.G. Optimization rules for SARS-CoV-2 Mpro antivirals: ensemble docking and exploration of the coronavirus protease active site. Viruses. 2020;12:942.", "ArticleIdList": ["PMC7552026", "32859008"]}, {"Citation": "Xue Q., Liu X., Russell P., Li J., Pan W., Fu J., Zhang A. Evaluation of the binding performance of flavonoids to estrogen receptor alpha by Autodock, Autodock Vina and Surflex-Dock. Ecotoxicol. Environ. Saf. 2022;233", "ArticleIdList": ["35183811"]}, {"Citation": "Lung J., Lin Y., Yang Y., Chou Y., Shu L., Cheng Y., Te Liu H., Wu C. The potential chemical structure of anti\u2010SARS\u2010CoV\u20102 RNA\u2010dependent RNA polymerase. J. Med. Virol. 2020;92:693\u2013697.", "ArticleIdList": ["PMC7228302", "32167173"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science. 2020;368:409\u2013412.", "ArticleIdList": ["PMC7164518", "32198291"]}, {"Citation": "Robinson M.C., Glen R.C. Validating the validation: reanalyzing a large-scale comparison of deep learning and machine learning models for bioactivity prediction. J. Comput. Aided Mol. Des. 2020;34:717\u2013730.", "ArticleIdList": ["PMC7292817", "31960253"]}, {"Citation": "Walters W.P., Barzilay R. Applications of deep learning in molecule generation and molecular property prediction. Acc. Chem. Res. 2020;54:263\u2013270.", "ArticleIdList": ["33370107"]}, {"Citation": "Kim J., Park S., Min D., Kim W. Comprehensive survey of recent drug discovery using deep learning. Int. J. Mol. Sci. 2021;22:9983.", "ArticleIdList": ["PMC8470987", "34576146"]}, {"Citation": "Joshi T., Joshi T., Pundir H., Sharma P., Mathpal S., Chandra S. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease. J. Biomol. Struct. Dyn. 2021;39:6728\u20136746.", "ArticleIdList": ["PMC7484589", "32752947"]}, {"Citation": "Nand M., Maiti P., Joshi T., Chandra S., Pande V., Kuniyal J.C., Ramakrishnan M.A. Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis. Sci. Rep. 2020;10:1\u201312.", "ArticleIdList": ["PMC7683650", "33230180"]}, {"Citation": "Chicco D., Warrens M.J., Jurman G. The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation. PeerJ. Comp. Sci. 2021;7:e623.", "ArticleIdList": ["PMC8279135", "34307865"]}, {"Citation": "Ghosh R., Chakraborty A., Biswas A., Chowdhuri S. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors\u2013an in silico docking and molecular dynamics simulation study. J. Biomol. Struct. Dyn. 2021;39:4362\u20134374.", "ArticleIdList": ["PMC7332865", "32568613"]}, {"Citation": "Zhou X., Zhong F., Lin C., Hu X., Zhang Y., Xiong B., Yin X., Fu J., He W., Duan J. Structure of SARS-CoV-2 main protease in the apo state. Sci. China Life Sci. 2021;64:656\u2013659.", "ArticleIdList": ["PMC7471536", "32880863"]}, {"Citation": "Kneller D.W., Phillips G., O'Neill H.M., Jedrzejczak R., Stols L., Langan P., Joachimiak A., Coates L., Kovalevsky A. Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography. Nat. Commun. 2020;11:3202. 2020.", "ArticleIdList": ["PMC7314768", "32581217"]}, {"Citation": "Ferreira J.C., Fadl S., Villanueva A.J., Rabeh W.M. Catalytic dyad residues His41 and Cys145 impact the catalytic activity and overall conformational fold of the main SARS-CoV-2 protease 3-chymotrypsin-like protease. Front. Chem. 2021;9:491.", "ArticleIdList": ["PMC8264439", "34249864"]}, {"Citation": "Narayanan A., Toner S.A., Jose J. Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases. Biochem. Soc. Trans. 2022;50:151\u2013165.", "ArticleIdList": ["35015073"]}, {"Citation": "Kumar S., Nyodu R., Maurya V.K., Saxena S.K. Coronavirus Disease 2019 (COVID-19) Springer; 2020. Morphology, genome organization, replication, and pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pp. 23\u201331."}, {"Citation": "Khan S., Fakhar Z., Hussain A., Ahmad A., Jairajpuri D.S., Alajmi M.F., Hassan M.I. Structure-based identification of potential SARS-CoV-2 main protease inhibitors. J. Biomol. Struct. Dyn. 2022;40:3595\u20133608.", "ArticleIdList": ["PMC7682383", "33210561"]}, {"Citation": "ul Qamar M.T., Alqahtani S.M., Alamri M.A., Chen L.-L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharmaceut. Anal. 2020;10:313\u2013319.", "ArticleIdList": ["PMC7156227", "32296570"]}, {"Citation": "S.S. Mousavi, A. Karami, T.M. Haghighi, S.G. Tumilaar, Fatimawali, Idroes, R. In silico evaluation of Iranian medicinal plant phytoconstituents as inhibitors against main protease and the receptor-binding domain of SARS-CoV-2. Molecules. 26 (2021) 5724.", "ArticleIdList": ["PMC8470205", "34577194"]}, {"Citation": "Peterson L. SSRN; 2020. COVID-19 and Flavonoids, Silico Molecular Dynamics Docking to the Active Catalytic Site of SARS-CoV and SARS-CoV-2 Main Protease."}, {"Citation": "Liu S.-Y., Wang W., Ke J.-P., Zhang P., Chu G.-X., Bao G.-H. Discovery of Camellia sinensis catechins as SARS-CoV-2 3CL protease inhibitors through molecular docking, intra and extra cellular assays. Phytomedicine. 2022;96", "ArticleIdList": ["PMC8575542", "34799184"]}, {"Citation": "Mahmud S., Biswas S., Paul G.K., Mita M.A., Promi M.M., Afrose S., Hasan M.R., Zaman S., Uddin M.S., Dhama K. Plant-based phytochemical screening by targeting main protease of SARS-CoV-2 to design effective potent inhibitors. Biology. 2021;10:589.", "ArticleIdList": ["PMC8301192", "34206970"]}, {"Citation": "Hanai T. Quantitative in silico analysis of SARS-CoV-2 S-RBD omicron mutant transmissibility. Talanta. 2022;240 doi: 10.1016/j.talanta.2022.123206.", "ArticleIdList": ["10.1016/j.talanta.2022.123206", "PMC8739820", "35026638"]}, {"Citation": "Choi K.-E., Kim J.-M., Rhee J., Park A.K., Kim E.-J., Kang N.S. Molecular Dynamics Studies on the structural characteristics for the stability prediction of SARS-CoV-2. Int. J. Mol. Sci. 2021;22:8714.", "ArticleIdList": ["PMC8395978", "34445414"]}, {"Citation": "Singh V.K., Chaurasia H., Kumari P., Som A., Mishra R., Srivastava R., Naaz F., Singh A., Singh R.K. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2. J. Biomol. Struct. Dyn. 2021:1\u201324.", "ArticleIdList": ["34253149"]}, {"Citation": "Dutta Dubey K., Kumar Tiwari R., Prasad Ojha R. Recent advances in protein\u2212 ligand interactions: molecular dynamics simulations and binding free energy. Curr. Comput. Aided Drug Des. 2013;9:518\u2013531.", "ArticleIdList": ["24138393"]}, {"Citation": "Mosquera-Yuqui F., Lopez-Guerra N., Moncayo-Palacio E.A. Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations. J. Biomol. Struct. Dyn. 2022;40:2010\u20132023.", "ArticleIdList": ["PMC7657401", "33084512"]}, {"Citation": "Mohapatra R.K., Dhama K., El\u2013Arabey A.A., Sarangi A.K., Tiwari R., Bin Emran T., Azam M., Al-Resayes S.I., Raval M.K., Seidel V. Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and in-silico pharmacokinetic and toxicity studies. J. King Saud Univ. Sci. 2021;33", "ArticleIdList": ["PMC8496942", "34642560"]}, {"Citation": "Yang H., Sun L., Li W., Liu G., Tang Y. In silico prediction of chemical toxicity for drug design using machine learning methods and structural alerts. Front. Chem. 2018;6:30.", "ArticleIdList": ["PMC5826228", "29515993"]}, {"Citation": "Segall M.D., Barber C. Addressing toxicity risk when designing and selecting compounds in early drug discovery. Drug Discov. Today. 2014;19:688\u2013693.", "ArticleIdList": ["24451294"]}, {"Citation": "Williams J.K., Wang B., Sam A., Hoop C.L., Case D.A., Baum J. Molecular dynamics analysis of a flexible loop at the binding interface of the SARS\u2010CoV\u20102 spike protein receptor\u2010binding domain, Proteins. Struct. Funct. Bioinformat. 2022;90:1044\u20131053.", "ArticleIdList": ["PMC8441656", "34375467"]}, {"Citation": "Esteves F., Rueff J., Kranendonk M. The central role of cytochrome P450 in xenobiotic metabolism\u2014a brief review on a fascinating enzyme family. J. Xenobio. 2021;11:94\u2013114.", "ArticleIdList": ["PMC8293344", "34206277"]}, {"Citation": "El-Banna A.A., Darwish R.S., Ghareeb D.A., Yassin A.M., Abdulmalek S.A., Dawood H.M. Metabolic profiling of Lantana camara L. using UPLC-MS/MS and revealing its inflammation-related targets using network pharmacology-based and molecular docking analyses. Sci. Rep. 2022;12:1\u201317.", "ArticleIdList": ["PMC9436993", "36050423"]}, {"Citation": "Swain S.S., Hussain T. Role of bioinformatics in early drug discovery: an overview and perspective. Computat. BioInformat.: Multidisc. Appl. 2021:49\u201367."}, {"Citation": "Lei T., Li Y., Song Y., Li D., Sun H., Hou T. ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling. J. Cheminf. 2016;8:1\u201319.", "ArticleIdList": ["PMC4736633", "26839598"]}, {"Citation": "Xu Y., Pei J., Lai L. Deep learning based regression and multiclass models for acute oral toxicity prediction with automatic chemical feature extraction. J. Chem. Inf. Model. 2017;57:2672\u20132685.", "ArticleIdList": ["29019671"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "19"}, {"Year": "2023", "Month": "2", "Day": "15"}, {"Year": "2023", "Month": "3", "Day": "10"}, {"Year": "2023", "Month": "3", "Day": "31", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "3", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "17", "Hour": "19", "Minute": "10"}, {"Year": "2023", "Month": "3", "Day": "11"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36931201", "PMC10008098", "10.1016/j.compbiomed.2023.106785", "S0010-4825(23)00250-0"]}}], "PubmedBookArticle": []}